Cytokinetics, Incorporated (CYTK) vs Hinge Health, Inc. (HNGE)

A side-by-side comparison of Cytokinetics, Incorporated and Hinge Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Cytokinetics, Incorporated logo
CYTK
Cytokinetics, Incorporated
$7.70B
$61.84HealthcareDelayed quote: Oct 6, 2026, 9:40 AM EDT
Hinge Health, Inc. logo
HNGE
Hinge Health, Inc.
$7.71B
$99.61HealthcareDelayed quote: Oct 6, 2026, 9:44 AM EDT

Total return — CYTK vs HNGE

growth of $100 · dividends reinvested · last 1y
CYTK +92.0% (+92.0%/yr)HNGE +161.8% (+161.8%/yr)HNGE compounded faster over this window
100150200250Start $1002026$192$262
CYTK HNGE

CYTK vs HNGE: by the numbers

  • •HNGE is the larger company ($7.71B vs $7.70B market cap).
  • •HNGE is profitable (15.15% net margin) while CYTK runs a net loss (-1259.87%).

Metrics side by side

Valuation

MetricCYTKHNGE
P/E ratioN/A77.42
Forward P/EN/A42.96
P/S ratio108.4410.70
P/B ratioN/A22.39
EV / EBITDAN/A76.03
FCF yieldN/A3.73%

Profitability

MetricCYTKHNGE
Gross margin84.97%84.52%
Operating margin-695.44%-92.94%
Net margin-1259.87%15.15%
ROEN/A31.68%
ROIC-39.80%26.62%

Growth (annualized)

MetricCYTKHNGE
Revenue CAGR (5Y)4.19%N/A
Total return CAGR (5Y)11.24%N/A

Frequently asked

Is CYTK or HNGE more profitable?
HNGE runs the higher net margin — CYTK at -1259.87% versus HNGE at 15.15%.

Go deeper

Full CYTK analysisFull HNGE analysisInteractive comparison tool

Dig into the metrics

Hinge Health P/E ratioCytokinetics ROEHinge Health ROECytokinetics operating marginHinge Health operating marginCytokinetics revenue growthHinge Health revenue growthCytokinetics free cash flowHinge Health free cash flow

Cytokinetics & Hinge Health appear in these rankings

Highest ROE StocksHighest ROIC StocksHighest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.